Practice A00-282 Exam Online

Question 1

In a clinical trial, the variable 'TreatmentGroup' indicates whether a patient received the experimental drug (coded as 'Drug') or the placebo (coded as 'Placebo'). You have been tasked with reporting the frequency and percentage of patients in each treatment group. Which SAS procedure would allow you to obtain these specific statistics for categorical data?

A : PROC MEANS

B : PROC UNIVARIATE

C : PROC FREQ

D : PROC CORR

Answer: C

Question 2

When implementing define.xml as part of a clinical trial study data submission package, which section is pivotal for explaining algorithmic derivations and handling of special data scenarios to a regulatory reviewer?

A : The dataset-level metadata section outlining dataset structure and content.

B : The variable-level metadata section describing characteristics and properties of each variable.

C : The computational algorithms and derivation methodology section clarifying complex programming logic.

D : The controlled terminology section ensuring conformance with industry standards for terminology.

Answer: C

Question 3

Suppose you are working on a project that requires creating a customized table that is not readily available from any SAS procedures, but you can generate the needed statistics. You need to capture these statistics in a dataset for further manipulation. Which ODS OUTPUT destination would you use to redirect the output of PROC MEANS to capture the necessary summary statistics in a SAS dataset?

A : ODS OUTPUT Summary=customstats;

B : ODS OUTPUT MeansData=customstats;

C : ODS OUTPUT OutputStatistics=customstats;

D : ODS OUTPUT SummaryStatistics=customstats;

Answer: B

Question 4

A clinical trial dataset is being prepared for statistical analysis and submission to a regulatory authority. Which of the following best describes the purpose of applying the CDISC Analysis Data Model (ADaM) standards to the dataset?

A : To define the dataset in a way that is specific to the individual clinical trial without consideration for cross-study comparisons.

B : To ensure that the dataset only includes variables that are directly derived from the Case Report Form (CRF).

C : To standardize the dataset structure and variables to facilitate efficient review by regulatory authorities and ensure consistency across studies.

D : To anonymize the clinical trial data to protect patient confidentiality before submission to regulatory agencies.

Answer: C

Question 5

During the execution of a SAS program, the programmer wants not only to display each step generated by macro execution but also to show the values of macro variables at execution time. Which combination of system options should the programmer use?

A : MPRINT and SYMBOLGEN

B : MLOGIC and SYMBOLGEN

C : MPRINT and MLOGIC

D : SYMBOLGEN and MACROGEN

Answer: A

Name:	Clinical Trials Programming Using SAS 9.4
Exam Code:	A00-282
Certification:	SAS Programming Fundamentals
Vendor:	SAS Institute
Total Questions:	145
Last Updated:	Oct 01, 2026

SAS Institute A00-282 Answers